Your browser doesn't support javascript.
loading
Simultaneous Quantification of Free Adalimumab and Infliximab in Human Plasma Using a Target-Based Sample Purification and Liquid Chromatography-Tandem Mass Spectrometry.
El Amrani, Mohsin; Bosman, Sabine M; Egas, Annelies C; Hack, C Erik; Huitema, Alwin D R; van Maarseveen, Erik M.
Afiliação
  • El Amrani M; Division of Laboratory Medicine and Pharmacy, Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University.
  • Bosman SM; Division of Laboratory Medicine and Pharmacy, Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University.
  • Egas AC; Division of Laboratory Medicine and Pharmacy, Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University.
  • Hack CE; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht.
  • Huitema ADR; Division of Laboratory Medicine and Pharmacy, Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University.
  • van Maarseveen EM; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Ther Drug Monit ; 41(5): 640-647, 2019 10.
Article em En | MEDLINE | ID: mdl-31584927
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasma / Adalimumab / Infliximab Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasma / Adalimumab / Infliximab Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article